University hospital Heidelberg

Heidelberg D-69120

9 studies enrolling now · 31 studies all time

What they study most

Acute Decompensated Heart Failure, Acute-On-Chronic Liver Failure, Advanced Multiple Myeloma, Aortic Aneurysm, Astrocytoma of Brain, Astrocytoma, Malignant, Breast Cancer, Candidemia, Cellular Apoptosis, Cerebrovascular Trauma, Chronic Hepatitis C Infection, Colitis, Ulcerative

Studies at this site

• Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary Hemochromatosis — Recruiting now
• Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread — Recruiting now
• Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258) — Recruiting now
• Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs — Recruiting now
• Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib — Recruiting now
• The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302) — Recruiting now
• The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203) — Recruiting now
• The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202) — Recruiting now
• The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections — Recruiting now
• The PEERLESS II Study — Running, not enrolling
• A Study of Barzolvolimab in Patients With Prurigo Nodularis — Running, not enrolling
• A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
• A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• ANCHOR (Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System Global Registry) — Completed
• Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC) — Completed
• An Efficacy and Safety Study of APX001 in Non-Neutropenic Patients With Candidemia — Completed
• A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis — Stopped early
• Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome. — Running, not enrolling
• ASSIST Registry Studying Various Operator Techniques — Completed
• The OPBC-07/microNAC Study — Running, not enrolling
• Nodal Burden and Nodal Recurrence in Patients With Isolated Tumor Cells After Neoadjuvant Chemotherapy Treated With Axillary Dissection or Nodal Radiation: the OPBC-05/EUBREAST-14R/ICARO Study — Completed
• Network Of Clinical Research Studies On Craniosynostosis, Skull Malformations With Premature Fusion Of Skull Bones — Running, not enrolling
• Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF — Completed
• Breathing-Induced Myocardial Oxygenation Reserve — Completed
• Study of Nivolumab in Unresectable Advanced or Recurrent Esophageal Cancer — Completed
• A Phase 2 Trial of Filanesib in Relapsed/Refractory Multiple Myeloma (AfFIRM) — Completed
• Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial — Stopped early
• Antihypertensive Treatment of Acute Cerebral Hemorrhage-II — Stopped early
• A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C — Completed
• A Study of Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C — Completed
• Observational Endothelin and Markers of Cellular Apoptosis In CSF Head Injury — Completed